Overview A Trial of HRS-1893 in Healthy Volunteers Status: RECRUITING Trial end date: 2025-09-30 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety and PK characteristics of a single oral dose of HRS-1893 in healthy voluunters.Phase: EARLY_PHASE1 Details Lead Sponsor: Atridia Pty Ltd.